Taros Chemicals, a privately owned CRO / CMO has been serving the needs of pharmaceutical, chemical and biotech companies since 1999. More than 10.000 synthesis, research and process chemistry projects have successfully been delivered to the global customer base. Taros’ scientists combine more than 140 years industrial organic chemistry experience and over 60 years of active drug discovery experience. They have expertise in major therapeutic areas and in all small molecule target classes.
Taros Chemical covers the full range of organometallic chemistry research and production from lab scale quantities to several hundred Kgs supplies per year. This includes screening/focused library design and production, computer aided drug design, medicinal chemistry services engaged in hit finding, hit to lead and lead optimization works as well as material science and specialty chemistry driven R&D services including research, design, route scouting, process development and non-GMP production & delivery of up to 1.000kg / year of such performance chemicals. Very recently Taros have designed and produced a series of HTS and Fragment based compound libraries that are very different in nature than what currently is available on the market with commercial vendors. The uniqueness of the designs has been related to in numerous scientific publications. Our compound libraries have a high degree of 3D structure and are unprecedented in the small molecules libraries of the pharmaceutical industry.